Orange Book product · Generic (ANDA)
E-MYCIN
ERYTHROMYCIN
At a glance
Approved Prior to Jan 1, 1982
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
No patent or exclusivity dates are listed for this product.
Pharmaceutical detail
Active ingredient
ERYTHROMYCIN
Strength
250MG
Dosage form
TABLET, DELAYED RELEASE
Route
ORAL
TE code
Not listed
Application
ANDA 060272
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of ERYTHROMYCIN
- 1987ERYGELBrand (NDA)
NDA 050617 · MYLAN
- 1986ERYTHROMYCINBrand (NDA)
NDA 050610 · PADDOCK LLC
- 1985ERYC SPRINKLESBrand (NDA)
NDA 050593 · HOSPIRA
- 1985ERYCETTEBrand (NDA)
NDA 050594 · JOHNSON AND JOHNSON
- 1985AKNE-MYCINBrand (NDA)
NDA 050584 · BAUSCH
- —ERYCBrand (NDA)
NDA 050536 · DR REDDYS LABS SA
- —ILOTYCINBrand (NDA)
NDA 050368 · DISTA
- —ERYTHROMYCINBrand (NDA)
NDA 050532 · LILLY
- —STATICINBrand (NDA)
NDA 050526 · WESTWOOD SQUIBB
- 2017ERYTHROMYCINGeneric (ANDA)
ANDA 208100 · ENCUBE
- 2017ERYTHROMYCINGeneric (ANDA)
ANDA 208154 · ENCUBE
- 2010ERYTHROMYCINGeneric (ANDA)
ANDA 090215 · EPIC PHARMA LLC
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
